SCOPUS 정보 검색 플랫폼

Volumn 5, Issue 5, 2006, Pages 478-480

Focal adhesion kinase signaling and the aggressive melanoma phenotype

(2) Hess, Angela R a Hendrix, Mary J C a

a NORTHWESTERN UNIVERSITY (United States)

Author keywords

Cell invasion; Cell migration; Erk1 2; Focal adhesion kinase (FAK); Melanoma; Proliferation; Urokinase; Vasculogenic mimicry

Indexed keywords

FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL ANCHORAGE; CELL INVASION; CELL MIGRATION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; PHENOTYPE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 33644782772 PISSN: 15384101 EISSN: 15514005 Source Type: Journal
DOI: 10.4161/cc.5.5.2518 Document Type: Article

Times cited : (65)

References (11)

1
- 0003964361
- Altanta, GA: American Cancer Society, American Cancer Society, Inc
- Cancer Facts and Figures 2005. Altanta, GA: American Cancer Society, 2005, [(Available from http://www.cancer.org) (American Cancer Society, Inc)].
- (2005) Cancer Facts and Figures 2005

2
- 27544479450
- Focal adhesion kinase promotes the aggressive melanoma phenotype
- Hess AR, Postovit LM, Margaryan NV, Seftor EA, Schneider GB, Seftor RE, Nickoloff BJ, Hendrix MJ. Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res 2005; 65:9851-60.
- (2005) Cancer Res , vol.65 , pp. 9851-9860
- Hess, A.R.¹ Postovit, L.M.² Margaryan, N.V.³ Seftor, E.A.⁴ Schneider, G.B.⁵ Seftor, R.E.⁶ Nickoloff, B.J.⁷ Hendrix, M.J.⁸

3
- 0035692448
- Drug resistance in melanoma: Mechanisms, apoptosis, and new potential therapeutic targets
- Grossman D, Altieri DC. Drug resistance in melanoma: Mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev 2001; 20:3-11.
- (2001) Cancer Metastasis Rev , vol.20 , pp. 3-11
- Grossman, D.¹ Altieri, D.C.²

4
- 3142745263
- Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: Implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma
- Amiri KI, Horton LW, LaFleur BJ, Sosman JA, Richmond A. Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: Implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. Cancer Res 2004; 64:4912-8.
- (2004) Cancer Res , vol.64 , pp. 4912-4918
- Amiri, K.I.¹ Horton, L.W.² LaFleur, B.J.³ Sosman, J.A.⁴ Richmond, A.⁵

5
- 0031059608
- Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis
- Jansen B, Schlagbauer-Wadl H, Eichler HG, Wolff K, van Elsas A, Schrier PI, Pehamberger H. Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis. Cancer Res 1997; 57:362-5.
- (1997) Cancer Res , vol.57 , pp. 362-365
- Jansen, B.¹ Schlagbauer-Wadl, H.² Eichler, H.G.³ Wolff, K.⁴ Van Elsas, A.⁵ Schrier, P.I.⁶ Pehamberger, H.⁷

6
- 22244452016
- Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells
- Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V, Bennett F, Pollock PM, Trent JM, Hendrix MJ, Rizzo P, Miele L, Nickoloff BJ. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res 2005; 65:6282-93.
- (2005) Cancer Res , vol.65 , pp. 6282-6293
- Qin, J.Z.¹ Ziffra, J.² Stennett, L.³ Bodner, B.⁴ Bonish, B.K.⁵ Chaturvedi, V.⁶ Bennett, F.⁷ Pollock, P.M.⁸ Trent, J.M.⁹ Hendrix, M.J.¹⁰ Rizzo, P.¹¹ Miele, L.¹² Nickoloff, B.J.¹³

7
- 27644545721
- Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines
- Smith CS, Golubovskaya VM, Peck E, Xu LH, Monia BP, Yang X, Cance WG. Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines. Melanoma Res 2005; 15:357-62.
- (2005) Melanoma Res , vol.15 , pp. 357-362
- Smith, C.S.¹ Golubovskaya, V.M.² Peck, E.³ Xu, L.H.⁴ Monia, B.P.⁵ Yang, X.⁶ Cance, W.G.⁷

8
- 0035948579
- Biochemical signals and biological responses elicited by the focal adhesion kinase
- Schaller MD. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta 2001; 1540:1-21.
- (2001) Biochim Biophys Acta , vol.1540 , pp. 1-21
- Schaller, M.D.¹

9
- 0034194714
- Matrix survival signaling: From fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase
- Almeida EA, Ilic D, Han Q, Hauck CR, Jin F, Kawakatsu H, Schlaepfer DD, Damsky CH. Matrix survival signaling: From fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J Cell Biol 2000; 149:741-54.
- (2000) J Cell Biol , vol.149 , pp. 741-754
- Almeida, E.A.¹ Ilic, D.² Han, Q.³ Hauck, C.R.⁴ Jin, F.⁵ Kawakatsu, H.⁶ Schlaepfer, D.D.⁷ Damsky, C.H.⁸

10
- 0035480032
- Anoikis mechanisms
- Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001; 13:555-62.
- (2001) Curr Opin Cell Biol , vol.13 , pp. 555-562
- Frisch, S.M.¹ Screaton, R.A.²

11
- 0029739950
- Control of adhesion-dependent cell survival by focal adhesion kinase
- Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996; 134:793-9.
- (1996) J Cell Biol , vol.134 , pp. 793-799
- Frisch, S.M.¹ Vuori, K.² Ruoslahti, E.³ Chan-Hui, P.Y.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.